INFUSYSTEM HOLDINGS, INC Cash and Cash Equivalents
INFUSYSTEM HOLDINGS, INC (INFU) had Cash and Cash Equivalents of $964.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-04
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $964.00K.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $2.11M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $3.19M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $955.00K.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $964.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $2.11M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $3.19M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $955.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $720.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.51M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $527.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $380.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $146.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $822.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $231.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $161.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $134.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $256.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $165.00K 10-K · filed 2024-04-10 |
| 2022-09-30 | $363.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $311.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $405.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $186.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $165.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $164.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.76M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $9.65M 10-K · filed 2022-03-15 |
| 2020-09-30 | $1.94M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $482.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $305.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.65M 10-K · filed 2021-03-22 |
| 2019-09-30 | $3.16M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.70M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.90M 10-Q · filed 2020-05-15 |
| 2018-12-31 | $4.32M 10-Q · filed 2020-05-15 |
| 2018-09-30 | $3.88M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $2.36M 10-Q · filed 2019-08-14 |
| 2018-03-31 | $1.53M 10-Q · filed 2019-05-15 |
| 2017-12-31 | $3.47M 10-K · filed 2020-03-30 |
| 2017-09-30 | $803.00K 10-Q · filed 2018-11-13 |
| 2017-06-30 | $76.00K 10-Q · filed 2018-08-14 |
| 2017-03-31 | $194.00K 10-Q · filed 2018-05-14 |
| 2016-12-31 | $3.40M 10-K · filed 2019-03-22 |
| 2016-09-30 | $1.07M 10-Q · filed 2017-11-13 |
| 2016-06-30 | $805.00K 10-Q · filed 2017-08-09 |
| 2016-03-31 | $569.00K 10-Q · filed 2017-05-15 |
| 2015-12-31 | $818.00K 10-K · filed 2018-03-19 |
| 2015-09-30 | $989.00K 10-Q · filed 2016-12-12 |
| 2015-06-30 | $791.00K 10-Q/A · filed 2016-12-12 |
| 2015-03-31 | $3.22M 10-Q/A · filed 2016-12-12 |
| 2014-12-31 | $515.00K 10-K · filed 2017-03-22 |
| 2014-09-30 | $1.90M 10-Q · filed 2015-11-12 |
| 2014-06-30 | $1.04M 10-Q · filed 2015-08-13 |
| 2014-03-31 | $496.00K 10-Q · filed 2015-05-12 |
| 2013-12-31 | $1.14M 10-K/A · filed 2016-12-12 |
| 2013-09-30 | $908.00K 10-Q · filed 2014-11-10 |
| 2013-06-30 | $102.00K 10-Q · filed 2014-08-01 |
| 2013-03-31 | $472.00K 10-Q · filed 2014-05-05 |
| 2012-12-31 | $2.33M 10-K · filed 2015-03-09 |
| 2012-09-30 | $1.46M 10-Q · filed 2013-11-12 |
| 2012-06-30 | $804.00K 10-Q · filed 2013-08-13 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-21 |
| 2011-12-31 | $799.00K 10-K · filed 2014-03-11 |
| 2011-09-30 | $433.00K 10-Q · filed 2012-11-14 |
| 2011-06-30 | $1.72M 10-Q · filed 2012-08-08 |
| 2011-03-31 | $3.18M 10-Q · filed 2012-05-21 |
| 2010-12-31 | $5.01M 10-K · filed 2013-03-28 |
| 2010-09-30 | $4.69M 10-Q · filed 2011-11-14 |
| 2010-06-30 | $3.02M 10-Q · filed 2011-08-15 |
| 2009-12-31 | $7.75M 10-K · filed 2012-03-16 |
| 2008-12-31 | $11.51M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |